JB Chemicals & Pharmaceuticals Limited NSE Symbol:JBCHEPHARM, BSE Security Code:506943 has declared its 4th(fourth) quarter audited Consolidated financial report from the month of January, 2020 to the month of March, 2020; for the fiscal year 2019-20.
| Revenue Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20 |
| Current Quarter (January, 2020 - March, 2020) |
Previous Quarter (October, 2019 - December, 2019) |
Corresponding Quarter (January, 2019 - March, 2019) |
12 Months Ended (April, 2019 - March, 2020) |
Corresponding 12 Months Ended (April, 2018 - March, 2019) |
| 446.74 |
445.01 |
434.57 |
1825.40 |
1684.64 |
| Calculated Revenue of JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20 |
| Current(March, 2020) VS Previous(December, 2019) |
Current(March, 2020) VS Corresponding(March, 2019) |
12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019) |
| Change |
Change % |
Change |
Change % |
Change |
Change % |
| 1.73 |
0.39%(Revenue Increase) |
12.17 |
2.80%(Revenue Increase) |
140.76 |
8.36%(Revenue Increase) |
Revenue: JB Chemicals & Pharmaceuticals Limited's financial report shows that the company's revenue increased by 0.39% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for revenue increase of Rs.1.73 crores, as the company posted revenue of Rs.446.74 crores; in compare to previous quarter(October, 2019 - December, 2019) when the company reported revenue of Rs.445.01 crores.
The result also shows that the company's revenue increased by 2.80% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for revenue increase of Rs.12.17 crores; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted revenue of Rs.434.57 crores
The company also reported that its revenue increased by 8.36% in 12 months end(April, 2019 - March, 2020) for revenue increase of Rs.140.76 crores, since the company reported revenue of Rs.1825.40 crores; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted revenue of Rs.1684.64 crores.
| Gross Margin(%) Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20 |
| Current Quarter (January, 2020 - March, 2020) |
Previous Quarter (October, 2019 - December, 2019) |
Corresponding Quarter (January, 2019 - March, 2019) |
12 Months Ended (April, 2019 - March, 2020) |
Corresponding 12 Months Ended (April, 2018 - March, 2019) |
| 62.73 |
63.34 |
64.69 |
64.01 |
61.35 |
| Calculated Gross Margin(%) of JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20 |
| Current(March, 2020) VS Previous(December, 2019) |
Current(March, 2020) VS Corresponding(March, 2019) |
12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019) |
| Change |
Change % |
Change |
Change % |
Change |
Change % |
| 0.62 |
0.97%(GM Decrease) |
1.97 |
3.04%(GM Decrease) |
2.65 |
4.33%(GM Increase) |
Gross Margin(%)/ GM: The company's financial report indicates, the company's GM decreased by 0.97% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for 0.62% GM decrease, as the company reported 62.73% GM; in compare to previous quarter(October, 2019 - December, 2019) when the company reported 63.34% GM.
The result also indicates, the company's GM decreased by 3.04% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for 1.97% GM decrease; in compare to corresponding quarter(January, 2019 - March, 2019) when the company reported 64.69% GM.
The company also reported that its GM increased by 4.33% in 12 months end(April, 2019 - March, 2020) for 2.65% GM increase, since the company reported 64.01% GM; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company reported 61.35% GM.
| EBITDA Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20 |
| Current Quarter (January, 2020 - March, 2020) |
Previous Quarter (October, 2019 - December, 2019) |
Corresponding Quarter (January, 2019 - March, 2019) |
12 Months Ended (April, 2019 - March, 2020) |
Corresponding 12 Months Ended (April, 2018 - March, 2019) |
| 84.91 |
105.98 |
81.19 |
418.24 |
347.28 |
| Calculated EBITDA of JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20 |
| Current(March, 2020) VS Previous(December, 2019) |
Current(March, 2020) VS Corresponding(March, 2019) |
12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019) |
| Change |
Change % |
Change |
Change % |
Change |
Change % |
| 21.07 |
19.88%(EBITDA Decrease) |
3.72 |
4.58%(EBITDA Increase) |
70.96 |
20.43%(EBITDA Increase) |
EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA decreased by 19.88% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for EBITDA decrease of Rs.21.07 crores, as the company posted EBITDA of Rs.84.91 crores; in compare to previous quarter(October, 2019 - December, 2019) when the company reported EBITDA of Rs.105.98 crores.
The result also shows that the company's EBITDA increased by 4.58% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for EBITDA increase of Rs.3.72 crores; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted EBITDA of Rs.81.19 crores
The company also reported that its EBITDA increased by 20.43% in 12 months end(April, 2019 - March, 2020) for EBITDA increase of Rs.70.96 crores, since the company reported EBITDA of Rs.418.24 crores; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted EBITDA of Rs.347.28 crores.
| Profit and Loss Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20 |
| Current Quarter (January, 2020 - March, 2020) |
Previous Quarter (October, 2019 - December, 2019) |
Corresponding Quarter (January, 2019 - March, 2019) |
12 Months Ended (April, 2019 - March, 2020) |
Corresponding 12 Months Ended (April, 2018 - March, 2019) |
| 50.07(Profit ) |
66.45(Profit ) |
46.79(Profit ) |
272.39(Profit ) |
193.97(Profit ) |
| Calculated Profit and Loss of JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20 |
| Current(March, 2020) VS Previous(December, 2019) |
Current(March, 2020) VS Corresponding(March, 2019) |
12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019) |
| Change |
Change % |
Change |
Change % |
Change |
Change % |
| 16.38 |
24.65%(Profit Decrease) |
3.28 |
7.01%(Profit Increase) |
78.42 |
40.43%(Profit Increase) |
Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit decreased by 24.65% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for profit decrease of Rs.16.38 crores, as the company posted profit of Rs.50.07 crores; in compare to previous quarter(October, 2019 - December, 2019) when the company reported profit of Rs.66.45 crores.
The result also shows that the company's profit increased by 7.01% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for profit increase of Rs.3.28 crores; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted profit of Rs.46.79 crores
The company also reported that its profit increased by 40.43% in 12 months end(April, 2019 - March, 2020) for profit increase of Rs.78.42 crores, since the company reported profit of Rs.272.39 crores; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted profit of Rs.193.97 crores.
| EPS Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20 |
| Current Quarter (January, 2020 - March, 2020) |
Previous Quarter (October, 2019 - December, 2019) |
Corresponding Quarter (January, 2019 - March, 2019) |
12 Months Ended (April, 2019 - March, 2020) |
Corresponding 12 Months Ended (April, 2018 - March, 2019) |
| 6.30 |
8.26 |
5.68 |
34.20 |
23.54 |
| Calculated EPS of JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20 |
| Current(March, 2020) VS Previous(December, 2019) |
Current(March, 2020) VS Corresponding(March, 2019) |
12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019) |
| Change |
Change % |
Change |
Change % |
Change |
Change % |
| 1.96 |
23.73%(EPS Decrease) |
0.62 |
10.92%(EPS Increase) |
10.66 |
45.28%(EPS Increase) |
EPS /Earning per Share: The company's financial report shows that the company's EPS decreased by 23.73% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for EPS decrease of Rs.1.96, as the company posted EPS of Rs.6.30; in compare to previous quarter(October, 2019 - December, 2019) when the company reported EPS of Rs.8.26.
The result also shows that the company's EPS increased by 10.92% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for EPS increase of Rs.0.62; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted EPS of Rs.5.68
The company also reported that its EPS increased by 45.28% in 12 months end(April, 2019 - March, 2020) for EPS increase of Rs.10.66, since the company reported EPS of Rs.34.20; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted EPS of Rs.23.54.
| Assets Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20 |
| Details |
Non-current Assets |
Current Assets |
| Current Quarter(March, 2020) |
Previous Year End(March, 2019) |
Current Quarter(March, 2020) |
Previous Year End(March, 2019) |
| Reported |
740.83 |
740.80 |
1072.73 |
1051.15 |
| |
Change |
Change % |
Change |
Change % |
| Calculated |
0.03 |
0.00%(Assets Increase) |
21.58 |
2.05%(Assets Increase) |
Assets:The company reported its non-current assets increased by 0.00% in current year end(March, 2020) for non-current assets increase of Rs.0.03 crore, since the company reported net non-current assets of Rs.740.83 crores; in compare to previous year end(March, 2019) when the company reported net non-current assets of Rs.740.80 crores.
The balance sheet of the company also shows that, its current assets increased by 2.05% in current year end(March, 2020) for current assets increase of Rs.21.58 crores, as the company reported net current assets of Rs.1072.73 crores; against previous year end(March, 2019) when the company reported net current assets of Rs.1051.15 crores.
| Liabilities Reported by JB Chemicals & Pharmaceuticals Limited for Fourth Quarter FY, 2019-20 |
| Details |
Non-current Liabilities |
Current Liabilities |
| Current Quarter(March, 2020) |
Previous Year End(March, 2019) |
Current Quarter(March, 2020) |
Previous Year End(March, 2019) |
| Reported |
62.72 |
64.84 |
312.85 |
244.18 |
| |
Change |
Change % |
Change |
Change % |
| Calculated |
2.12 |
3.27%(Liabilities Decrease) |
68.67 |
28.12%(Liabilities Increase) |
Liabilities:The company reported its non-current liabilities decreased by 3.27% in current year end(March, 2020) for non-current liabilities decrease of Rs.2.12 crores, since the company reported net non-current liabilities of Rs.62.72 crores; in compare to previous year end(March, 2019) when the company reported net non-current liabilities of Rs.64.84 crores.
The balance sheet of the company also shows that, its current liabilities increased by 28.12% in current year end(March, 2020) for current liabilities increase of Rs.68.67 crores, as the company reported net current liabilities of Rs.312.85 crores; against previous year end(March, 2019) when the company reported net current liabilities of Rs.244.18 crores.
***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.
Add new comment